Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia

Please always quote using this URN: urn:nbn:de:bvb:20-opus-116550
  • The majority of patients with acute myeloid leukemia will relapse, and older patients often fail to achieve remission with induction chemotherapy. We explored the possibility that leukemic suppression of innate immunity might contribute to treatment failure. Natural killer cell phenotype and function was measured in 32 consecutive acute myeloid leukemia patients at presentation, including 12 achieving complete remission. Compared to 15 healthy age-matched controls, natural killer cells from acute myeloid leukemia patients were abnormal atThe majority of patients with acute myeloid leukemia will relapse, and older patients often fail to achieve remission with induction chemotherapy. We explored the possibility that leukemic suppression of innate immunity might contribute to treatment failure. Natural killer cell phenotype and function was measured in 32 consecutive acute myeloid leukemia patients at presentation, including 12 achieving complete remission. Compared to 15 healthy age-matched controls, natural killer cells from acute myeloid leukemia patients were abnormal at presentation, with downregulation of the activating receptor NKp46 (P=0.007) and upregulation of the inhibitory receptor NKG2A (P=0.04). Natural killer cells from acute myeloid leukemia patients had impaired effector function against autologous blasts and K562 targets, with significantly reduced CD107a degranulation, TNF-alpha and IFN-gamma production. Failure to achieve remission was associated with NKG2A overexpression and reduced TNF-alpha production. These phenotypic and functional abnormalities were partially restored in the 12 patients achieving remission. In vitro co-incubation of acute myeloid leukemia blasts with natural killer cells from healthy donors induced significant impairment in natural killer cell TNF-alpha and IFN-gamma production (P=0.02 and P=0.01, respectively) against K562 targets and a trend to reduced CD107a degranulation (P=0.07). Under transwell conditions, the inhibitory effect of AML blasts on NK cytotoxicity and effector function was still present, and this inhibitory effect was primarily mediated by IL-10. These results suggest that acute myeloid leukemia blasts induce long-lasting changes in natural killer cells, impairing their effector function and reducing the competence of the innate immune system, favoring leukemia survival.show moreshow less

Download full text files

Export metadata

Additional Services

Share in Twitter Search Google Scholar Statistics
Metadaten
Author: Kate Stringaris, Takuya Sekine, Ahmad Khoder, Abdullah Alsuliman, Bonni Razzaghi, Ruhena Sargeant, Jiri Pavlu, Gill Brisley, Hugues de Lavallade, Anushruthi Sarvaria, Anushruthi Sarvaria, Stephan Mielke, Jane F. Apperley, Elisabeth J. Shpall, A. John Barrett, Katayoun Rezvani
URN:urn:nbn:de:bvb:20-opus-116550
Document Type:Journal article
Faculties:Medizinische Fakultät / Medizinische Klinik und Poliklinik II
Language:English
Parent Title (English):Haematologica
ISSN:1592-8721
Year of Completion:2014
Volume:99
Issue:5
Pagenumber:836-847
Source:haematologica | 2014; 99(5), 836-847. doi:10.3324/haematol.2013.087536
DOI:https://doi.org/10.3324/haematol.2013.087536
Pubmed Id:https://pubmed.ncbi.nlm.nih.gov/24488563
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Tag:MHC molecules; activating receptors; acute myelogenous leukemia; class-I; cytotoxicity receptors; inhibitory receptors; ligand incompatibility; missing self; resting NK cells; virus-infected cells
Release Date:2015/07/30
Licence (German):License LogoDeutsches Urheberrecht